Psychemedics Corporation (PMD) EV/EBITDA Multiple
Psychemedics (PMD) relies on a high-tech molecular research center in California, where automation ensures testing accuracy. The business focuses on providing law enforcement and corporations with precision hair analysis for drug detection with an extended detection window. The current EV/EBITDA ratio is . This price chart clearly demonstrates the valuation dynamics for the company.
Analytical breakdowns for Psychemedics
- market price and analyst price targets:
- market capitalization details:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Psychemedics|PMD - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Psychemedics Corporation|PMD - Company Cumulative Debt|Debts to Book Capitalization Psychemedics Inc|PMD - Company Long-Term Liabilities|Company Short-Term Debts Psychemedics|Quick Ratio psychemedics.com
- business earnings and investment ratios data:
PMD - Company Net Income|Expected Profit Psychemedics|PMD - Price to Earnings Ratio|Forward P/E Multiple Psychemedics|PMD - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Psychemedics Inc|PMD - Operating profit before amortization|Net earnings per share (EPS TTM) Psychemedics|PMD - Net earnings per share for the last four quarters|Quarterly EPS earnings growth psychemedics.com|PMD - Net earnings per share growth this year|Net earnings per share growth forecast for next year Psychemedics
Initial company analysis:Psychemedics Corp PMD
Steady demand for innovative drugs from Psychemedics makes the business a defensive asset independent of global macroeconomics. This metric compares the total enterprise value, accounting for debt and taxes, to operating profit, reflecting market expectations for scaling. An increase in the business's EV/EBITDA multiple signals that future excess returns are being priced in, while a decrease indicates a real contraction in margins.
Competitors of Psychemedics (PMD)
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Quest Corp (DGX)|Illumina, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|Revvity (RVTY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho (QDEL)|Total Company Value to Operating Income Before Depreciation Ratio opko.com|CareDx Inc - Enterprise Value to EBITDA Ratio|Maravai LifeSciences Holdings (MRVI) - Company Value to EBITDA|Fulgent Corp - EV/EBITDA Multiple|Standard BioTools Corp (LAB) - Enterprise Value to EBITDA Ratio|CTKB: EV/EBITDA Multiple|orasure.com - Business Value to Operating Income Before Depreciation|XGN (Exagen Inc) - EV/EBITDA Multiple|Company Value to EBITDA MDxHealth S.A. MDXH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lucid Diagnostics Inc (LUCD)|Enterprise Value to EBITDA Ratio prenetics.com PRE|EV/EBITDA Multiple IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC (TRIB) - Company Value to EBITDA|ProPhase Labs - EV/EBITDA Multiple|AIMD (Ainos Inc) - Enterprise Value to Operating Income Before Depreciation|CODX: EV/EBITDA Multiple|HSCS - Total Company Value to Operating Income Before Depreciation Ratio|BMRA (Biomerica, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cardio Diagnostics Holdings, Inc. (CDIO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Onconetix (ONCO)|Total Company Value to Operating Income Before Depreciation Ratio Virax Biolabs Group Limited|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bluejay BJDX|AWH (Aspira Women's Health Inc) - Company Value to Operating Income Before Depreciation Ratio|AXDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Centogene (CNTG) - Enterprise Value to EBITDA Ratio|ENZ: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation FRES|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Genetic Technologies Ltd|Enterprise Value to EBITDA Ratio 23andMe Inc (ME)
